Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Front Microbiol ; 13: 996214, 2022.
Article in English | MEDLINE | ID: mdl-36312963

ABSTRACT

Worldwide dissemination of extended-spectrum -lactamase (ESBL)-producing Escherichia coli constitutes an emerging global health issue, with animal food products contributing as potential reservoirs. ESBL E. coli infection is associated with the high mortality and mobility rate in developing countries due to less susceptibility to antibiotics. The present study aimed to elucidate the molecular characteristics and sequence-based analysis of ESBL E. coli in the Gujarat state of India. This study included 108 E. coli strains were isolated from different poultry farms (broiler and layer) in the Banaskantha District. PCR was employed to identify genotypic ESBL-producing antimicrobial resistance genes. Overall, a high occurrence of ESBL genes was found in poultry farms due to the high usage of antimicrobials. The PCR analysis revealed that 79.62% of isolates were detected positive with one or more ESBL genes. Among them, bla TEM (63.88%) was found to be the predominant genotype, followed by bla SHV (30.55%) and bla OXA (28.70%). In the bla CTX-M group, a higher occurrence was observed in bla CTX-M-9 (23.14%), followed by bla CTX-M-2 (24.07%) and bla CTX-M-1 (22.22%). We used the whole-genome sequencing (WGS) method to evaluate the antimicrobial resistance genes, virulence factors, single nucleotide polymorphisms (SNPs), plasmid replicons, and plasmid-mediated AMR genes of one ESBL E. coli isolated. We examined the genetic relatedness of a human pathogenic E. coli strain by comparing its sequence with the broad geographical reference E. coli sequences. Escherichia coli ST 681 was determined using multi-locus sequence typing. We compared our findings to the reference sequence of Escherichia coli str. K- 12 substr. MG1655. We found 24,937 SNPs with 21,792 in the genic region, 3,145 in the intergenic region, and six InDels across the genome. The WGS analysis revealed 46 antimicrobial resistance genes and seven plasmid-mediated AMR genes viz., tetA, qnrS1, dfrA14, sul2, aph(3")-lb, aph(6)-ld, and Aph(3')-la. The ST 681 was found to have Cib, traT, and terC virulence factors and two plasmid replicons, IncFII(pHN7A8) and IncI1-I(Alpha). This study revealed a higher occurrence of ESBL E. coli detected in poultry.

2.
AJNR Am J Neuroradiol ; 38(8): 1536-1542, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28596188

ABSTRACT

BACKGROUND AND PURPOSE: Intracerebral hemorrhage accounts for 6.5%-19.6% of all acute strokes. Initial intracerebral hemorrhage volume and expansion are both independent predictors of clinical outcomes and mortality. Therefore, a rapid, unbiased, and precise measurement of intracerebral hemorrhage volume is a key component of clinical management. The most commonly used method, ABC/2, results in overestimation. We developed an interactive segmentation program, SegTool, using a novel graphic processing unit, level set algorithm. Until now, the speed, bias, and precision of SegTool had not been validated. MATERIALS AND METHODS: In a single stroke academic center, 2 vascular neurologists and 2 neuroradiologists independently performed a test-retest experiment that involved repeat measurements of static, unchanging intracerebral hemorrhage volumes on CT from 76 intracerebral hemorrhage cases. Measurements were made with SegTool and ABC/2. True intracerebral hemorrhage volumes were estimated from a consensus of repeat manual tracings by 2 operators. These data allowed us to estimate measurement bias, precision, and speed. RESULTS: The measurements with SegTool were not significantly different from the true intracerebral hemorrhage volumes, while ABC/2 overestimated volume by 45%. The interrater measurement variability with SegTool was 50% less than that with ABC/2. The average measurement times for ABC/2 and SegTool were 35.7 and 44.6 seconds, respectively. CONCLUSIONS: SegTool appears to have attributes superior to ABC/2 in terms of accuracy and interrater reliability with a 9-second delay in measurement time (on average); hence, it could be useful in clinical trials and practice.


Subject(s)
Algorithms , Cerebral Hemorrhage/diagnostic imaging , Computer Simulation , Tomography, X-Ray Computed/methods , Cerebral Hemorrhage/pathology , Humans , Reproducibility of Results , Retrospective Studies
3.
Genome Announc ; 4(5)2016 Oct 27.
Article in English | MEDLINE | ID: mdl-27789633

ABSTRACT

Brucella abortus is generally known to cause brucellosis in cattle and buffalo. Here, we report the draft genome sequence of Brucella abortus SKN 13, isolated from aborted cattle placenta in the area of Gujarat, India, providing precious resources for comparative genomic analyses of Brucella field strains.

4.
Vet World ; 8(11): 1370-4, 2015 Nov.
Article in English | MEDLINE | ID: mdl-27047045

ABSTRACT

AIM: Tropical theileriosis is fatal hemoprotozoal disease of dairy animals caused by Theileria annulata. The aim of the present study was to detect the T. annulata and comparison of results of molecular and microscopic techniques. MATERIALS AND METHODS: A total of 52 blood samples were collected from the cattle suspected for theileriosis across the Banaskantha district. All the samples were screened for theileriosis using Giemsa's staining technique and polymerase chain reaction (PCR). RESULTS: Total of 17 (32.69%) and 24 (46.15%) samples were found positive for theileriosis by microscopic examination and PCR test, respectively. It revealed that the study area is endemic for theileriosis, and the microscopic technique has 70.83% sensitivity and 100% specificity with respect to PCR technique. CONCLUSION: It may be concluded from the present study that the PCR is comparatively sensitive technique than microscopic examination and may be recommended to use in the field for screening of theileriosis in the study area, where a high prevalence of diseases have been reported due to intensive dairy farming.

5.
AJNR Am J Neuroradiol ; 35(4): 644-9, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24113467

ABSTRACT

BACKGROUND AND PURPOSE: CT performed with Veo model-based iterative reconstruction has shown the potential for radiation-dose reduction. This study sought to determine whether Veo could reduce noise and improve the image quality of low-dose sinus CT. MATERIALS AND METHODS: Twenty patients consented to participate and underwent low- and standard-dose sinus CT on the same day. Standard-dose CT was created with filtered back-projection (120 kV[peak], 210 mA, 0.4-second rotation, and 0.531 pitch). For low-dose CT, mA was decreased to 20 (the remaining parameters were unchanged), and images were generated with filtered back-projection and Veo. Standard- and low-dose datasets were reconstructed by using bone and soft-tissue algorithms, while the low-dose Veo reconstruction only had a standard kernel. Two blinded neuroradiologists independently evaluated the image quality of multiple osseous and soft-tissue craniofacial structures. Image noise was measured by using multiple regions of interest. RESULTS: Eight women and 12 men (mean age, 63.3 years) participated. Volume CT dose indices were 2.9 mGy (low dose) and 31.6 mGy (standard dose), and mean dose-length products were 37.4 mGy-cm (low dose) and 406.1 mGy-cm (standard dose). Of all the imaging series, low-dose Veo demonstrated the least noise (P < .001). Compared with filtered back-projection low-dose CT using soft-tissue and bone algorithms, Veo had the best soft-tissue image quality but the poorest bone image quality (P < .001). CONCLUSIONS: Veo significantly reduces noise in low-dose sinus CT. Although this reduction improves soft-tissue evaluation, thin bone becomes less distinct.


Subject(s)
Multidetector Computed Tomography/methods , Paranasal Sinus Diseases/diagnostic imaging , Radiation Dosage , Aged , Algorithms , Artifacts , Brain/diagnostic imaging , Cohort Studies , Eye/diagnostic imaging , Female , Humans , Male , Middle Aged , Multidetector Computed Tomography/standards , Preoperative Care/methods , Preoperative Care/standards , Radiographic Image Enhancement/methods , Radiographic Image Enhancement/standards
7.
AJNR Am J Neuroradiol ; 30(3): 516-9, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18842766

ABSTRACT

A 53-year-old woman with superficial siderosis underwent spinal MR imaging, which demonstrated a large cervicothoracic epidural fluid collection compatible with a CSF leak. Conventional and dynamic CT myelography failed to localize the dural tear because of rapid equilibration of myelographic contrast between the thecal sac and the extradural collection. The superior temporal resolution of digital subtraction myelography precisely localized the CSF leak preoperatively and led to the successful surgical correction of the dural tear.


Subject(s)
Cerebrospinal Fluid , Dura Mater/pathology , Intracranial Hypotension/surgery , Magnetic Resonance Imaging , Myelography/methods , Dura Mater/surgery , Epidural Space , Female , Hearing Loss, Sensorineural/etiology , Humans , Intracranial Hypotension/etiology , Intracranial Hypotension/pathology , Middle Aged , Preoperative Care , Subtraction Technique , Thoracic Vertebrae
8.
AJNR Am J Neuroradiol ; 27(10): 2112-4, 2006.
Article in English | MEDLINE | ID: mdl-17110677

ABSTRACT

Copper deficiency has been associated with a clinical syndrome, myeloneuropathy. Radiographic changes resembling B(12) deficiency in the cervical spinal cord have been described. We present a case of copper deficiency myeloneuropathy, with cervical MR imaging findings resembling B(12) deficiency, which partially reversed following copper supplementation. This is, to our knowledge, the first described case of radiographic improvement with copper supplementation.


Subject(s)
Copper/deficiency , Magnetic Resonance Imaging , Spinal Cord Diseases/diagnosis , Vitamin B 12 Deficiency/diagnosis , Copper/therapeutic use , Diagnosis, Differential , Female , Humans , Middle Aged , Spinal Cord Diseases/drug therapy
10.
Br J Plast Surg ; 54(6): 547-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11513522

ABSTRACT

The ipsilateral posterior thigh flap has become one of the workhorses for the closure of ischial pressure ulcers. We treated a 40-year-old paraplegic patient with a right ischial pressure ulcer, in whom all ipsilateral flap options had been expended or were precluded by scars. A contralateral left posterior thigh fasciocutaneous flap interpolated subcutaneously across the midline provided successful coverage.


Subject(s)
Paraplegia/complications , Pressure Ulcer/surgery , Surgical Flaps , Adult , Body Constitution , Humans , Male , Pressure Ulcer/etiology , Treatment Outcome
12.
Carcinogenesis ; 21(9): 1691-700, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10964101

ABSTRACT

Primary lung tumors from B6C3F1 mice and mouse lung cell lines were examined to investigate the role of transcriptional silencing of the p16 (Ink4a) tumor suppressor gene by DNA hypermethylation during mouse lung carcinogenesis. Hypermethylation (>/=50% methylation at two or more of the CpG sites examined) of the p16 (Ink4a) promoter region was detected in DNA from 12 of 17 (70%) of the B6C3F1 primary mouse lung adenocarcinomas examined, whereas hypermethylation was not detected in normal B6C3F1, C57BL/6 and C3H/He mouse lung tissues. Immunohistochemistry performed on the B6C3F1 lung adenocarcinomas revealed heterogeneous expression of the p16 protein within and among the tumors. Laser capture microdissection was employed to collect cells from immunostained sections of four tumors displaying areas of relatively high and low p16 expression. The methylation status of the microdissected samples was assessed by sodium bisulfite genomic sequencing. The pattern of p16 expression correlated inversely with the DNA methylation pattern at promoter CpG sites in nine of 11 (82%) of the microdissected areas displaying variable p16 expression. To provide further evidence that hypermethylation is involved in the loss of p16 (Ink4a) gene expression, three mouse lung tumor cell lines (C10, sp6c and CMT64) displaying complete methylation at seven promoter CpG sites and no p16 (Ink4a) expression were treated with the demethylating agent, 5-aza-2'-deoxycytidine. Re-expression of p16 (Ink4a) and partial demethylation of the p16 (Ink4a) promoter were observed in two cell lines (C10 and sp6c) following treatment. These are the first reported studies to provide strong evidence that DNA methylation is a mechanism for p16 inactivation in mouse lung tumors.


Subject(s)
Adenocarcinoma/genetics , Azacitidine/analogs & derivatives , Carrier Proteins/genetics , DNA Methylation , DNA, Neoplasm/genetics , Lung Neoplasms/genetics , Promoter Regions, Genetic/physiology , Adenocarcinoma/metabolism , Animals , Antimetabolites, Antineoplastic/pharmacology , Azacitidine/pharmacology , Carrier Proteins/biosynthesis , Cell Division/drug effects , CpG Islands/physiology , Cyclin-Dependent Kinase Inhibitor p16 , DNA Methylation/drug effects , DNA Modification Methylases/antagonists & inhibitors , DNA Mutational Analysis , DNA, Neoplasm/metabolism , Decitabine , Female , Gene Expression , Genes, Tumor Suppressor , Immunohistochemistry , Loss of Heterozygosity , Lung Neoplasms/metabolism , Mice , Mice, Inbred A , Mice, Inbred C3H , Mice, Inbred C57BL , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured
13.
Magn Reson Med ; 39(1): 61-7, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9438438

ABSTRACT

To evaluate the sensitivity of fast, gradient-echo MR scan techniques in their ability to detect blood oxygenation level dependent (BOLD) signal changes in task activation studies, three dedicated fast scan techniques, each with whole-brain coverage, were compared during a 3-min finger tapping paradigm on nine normal volunteers on a clinical 1.5 T scanner. Multislice (2D) single-shot spiral, 3D spiral, and multislice (2D) single-shot EPI scan techniques were done with similar temporal and spatial resolutions on each of the volunteers in random order. After image registration and statistical analysis, the sensitivity to detect activation was evaluated for the techniques by calculating t scores and number of activated voxels in predetermined regions of interest, including the contralateral primary sensorimotor cortex, the premotor region, the parietal region, the supplementary motor area, and the ipsilateral cerebellum. Baseline images acquired with the three techniques were qualitatively comparable and had a similar effective spatial resolution of around 5 x 5 x 5 mm3, as determined from autocorrelation analysis. The anatomical coverage was somewhat reduced (4 less slices per volume) with EPI at the identical temporal resolution of 1.76 s for all techniques. The use of multislice 2D spiral scan for motor cortex fMRI experiments provided for a superior overall temporal stability, and an increased sensitivity compared with multislice 2D EPI, and 3D spiral scan. The difference in sensitivity between multislice 2D spiral and EPI scans was small, in particular in the case of a ramp-sampled version of EPI. The difference in performance is attributed mainly to the difference in scan-to-scan stability.


Subject(s)
Brain/anatomy & histology , Magnetic Resonance Imaging/methods , Brain/physiology , Computer Simulation , Echo-Planar Imaging/instrumentation , Echo-Planar Imaging/methods , Humans , Image Interpretation, Computer-Assisted , Models, Neurological , Reference Values , Sensitivity and Specificity
14.
Carcinogenesis ; 18(9): 1751-5, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9328171

ABSTRACT

In this study we investigated the mouse mad-related genes, Smad4/Dpc4 and Smad2 (homolog of JV18-1), as candidates for involvement in lung tumor resistance and suppression. These genes are located in a region of mouse chromosome 18 that is syntenic with human 18q21.1, where several genes that are mutated in various cancers have been mapped. A newly identified murine lung tumor resistance locus, Par2 has also been mapped to this region of chromosome 18. We found no mutations in the coding regions of either gene in 11 lung tumors from B6CF1 (C57BL/6 x BALB/c) mice by RT-PCR and SSCP/RFLP, suggesting that these genes are not mutated in lung carcinogenesis in this strain. Moreover, loss of heterozygosity in this region of chromosome 18 was not detected in 28 lung adenocarcinomas from B6CF1 mice, 17 lung adenocarcinomas from B6C3F1 mice or 18 lung adenocarcinomas from AB6F1 mice. These data provide evidence that a 'classical' tumor suppressor gene for mouse lung carcinogenesis in these strains does not reside in this region. In order to investigate Smad4/Dpc4 and Smad2 as candidates for the Par2 resistance locus mapped to this region, we also sequenced the coding regions of both genes in cDNA from normal lungs of A/J, BALB/c and C57BL/6 inbred strains of mice. No polymorphisms were detected in the coding region of Smad4. In Smad2, two sequence polymorphisms were identified that are not in the conserved regions of the gene. Northern blot analysis revealed no differential expression in normal lung tissue among the three strains for either gene. Thus, in this study we found no evidence that either Smad4 or Smad2 represents the Par2 lung tumor resistance locus or is a lung tumor suppressor gene in the B6CF1 mice.


Subject(s)
DNA-Binding Proteins , Genes, Tumor Suppressor , Lung Neoplasms/genetics , Trans-Activators/genetics , Animals , Female , Gene Deletion , Genetic Predisposition to Disease , Humans , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Polymorphism, Genetic , Smad4 Protein , Species Specificity
15.
Scand J Gastroenterol ; 32(10): 965-73, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9361167

ABSTRACT

BACKGROUND: The efficacy of omeprazole, 20 mg once daily, in the treatment of reflux oesophagitis and the therapeutic advantages over the histamine H2 receptor antagonists are well documented. This study assessed 20 mg omeprazole daily (OM20), 10 mg omeprazole daily (OM10), and 150 mg ranitidine (RAN) twice daily for symptom relief in gastro-oesophageal reflux disease (GORD). METHODS: Patients (n = 994) presenting with heartburn to their general practitioner underwent endoscopy to exclude peptic ulcer disease and were randomized into a UK, multicentre, parallel-group, double-blind comparison of the three treatments for 4 weeks. Symptoms were assessed at clinic visits after 2 and 4 weeks. RESULTS: Symptom relief after 4 weeks was achieved by 61% (OM20), 49% (OM10), and 40% (RAN) patients (OM20 versus OM10, P < 0.0167; OM20 versus RAN, P < 0.0001; OM10 versus RAN, P < 0.01). Among the patients (32%) with erosive reflux oesophagitis, symptom relief was achieved in 79% (OM20), 48% (OM10), and 33% (RAN) (OM20 versus OM10, P < 0.0001; OM20 versus RAN, P < 0.0001; OM1O versus RAN, NS). CONCLUSION: Omeprazole, 20 mg, is the most effective initial therapy for relief of GORD symptoms.


Subject(s)
Anti-Ulcer Agents/administration & dosage , Gastroesophageal Reflux/drug therapy , Omeprazole/administration & dosage , Ranitidine/administration & dosage , Double-Blind Method , Drug Administration Schedule , Female , Heartburn/drug therapy , Humans , Male , Middle Aged , Time Factors
16.
Scand J Gastroenterol ; 32(7): 627-32, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9246699

ABSTRACT

BACKGROUND: Gastro-oesophageal reflux disease (GORD) is a frequent cause for consultation in general practice and is a chronically relapsing disease. METHODS: This general practice study was a 6-month randomized, double-blind parallel-group placebo-controlled assessment of the efficacy and safety of continuous treatment with 10 mg omeprazole every morning after initial symptom control in 495 patients with GORD but without erosive oesophagitis. RESULTS: On the basis of life-table estimates for cumulative relapse rates, patients in the placebo group (52%) were almost twice as likely as those in the omeprazole group (27%) to discontinue therapy before 24 weeks because of inadequate relief of heartburn or for other reasons including adverse events (all-patients-treated analysis, log rank test, P = 0.0001). CONCLUSIONS: This study has shown that 10 mg omeprazole once daily is an effective and well-tolerated treatment strategy in general practice for the long-term management of symptoms of GORD in patients without erosive oesophagitis.


Subject(s)
Anti-Ulcer Agents/administration & dosage , Gastroesophageal Reflux/drug therapy , Omeprazole/administration & dosage , Anti-Ulcer Agents/therapeutic use , Double-Blind Method , Drug Administration Schedule , Family Practice , Female , Humans , Life Tables , Male , Middle Aged , Omeprazole/therapeutic use , Recurrence , Time Factors
18.
Eur J Pharmacol ; 300(1-2): 113-7, 1996 Apr 04.
Article in English | MEDLINE | ID: mdl-8741175

ABSTRACT

Autoradiographic binding studies using [125I]S(-)-zacopride (0.1 nM) identified non-5-HT3 specific binding sites (defined by 5-hydroxytryptamine (5-HT), 1.0 microM) in the rat duodenum and ileum and some other peripheral tissues (adrenal gland, liver, stomach, kidney and spleen). In the rat duodenum and ileum, saturation studies with [125I]S(-)-zacopride indicated that the specific binding was saturable and of high affinity to an apparently homogenous population of binding sites (duodenum Bmax = 1.88 fmol/mg, Kd = 0.078 nM; ileum Bmax = 1.60 fmol/mg, Kd = 0.071 nM). Competition studies with slices of either duodenum or ileum indicated that the pharmacology of the [125I]S(-)-zacopride recognition site in both tissues was comparable but differed from all 5-HT receptors and uptake sites reported to date. However, the [125I]S(-)-zacopride recognition site displayed some pharmacological and regional similarity to the 5-HT1P recognition site: The sensitivity of the [125I]S(-)-zacopride binding in the duodenum and ileum to GTP indicates that the radiolabelled recognition site may represent a functional G-protein coupled receptor.


Subject(s)
Benzamides/metabolism , Bridged Bicyclo Compounds, Heterocyclic/metabolism , Duodenum/metabolism , Ileum/metabolism , Serotonin Antagonists/metabolism , Animals , Autoradiography , Benzamides/pharmacology , Binding Sites , Binding, Competitive , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Female , Guanosine Triphosphate/pharmacology , Rats , Rats, Wistar , Serotonin Antagonists/pharmacology
19.
Ophthalmology ; 101(8): 1373-8, 1994 Aug.
Article in English | MEDLINE | ID: mdl-8058282

ABSTRACT

BACKGROUND: In more than 50% of eyes with idiopathic, full-thickness macular holes, vitrectomy results in clinical closure of the hole and improvement in visual acuity. Other than cataract formation, late complications of the procedure have not been reported. METHODS: Over a 4-year period, 167 eyes underwent successful vitreous surgery for idiopathic macular holes documented by clinical closure of the hole and an improvement in visual acuity of at least two Snellen lines. The authors retrospectively studied eight of these eyes. All initially had successful surgery; however, they subsequently had spontaneous late re-opening of the macular hole with acute diminution in vision. RESULTS: Late re-opening developed in these eyes between 2 and 22 months after initial surgery. The mean time for re-opening was 12.5 months. Three of eight eyes underwent a second vitrectomy, which was successful in improving visual acuity in two eyes. Another patient manifested the growth of an epiretinal membrane that apparently sealed the re-opened macular hole and improved vision. CONCLUSION: Late re-opening can complicate initially successful macular hole surgery and may occur in at least 4.8% (8 of 167) of initially successful operations. Re-opening has been documented as late as 22 months after initial surgery. Repeat vitrectomy with gas injection may result in reclosure of the hole and improvement in vision.


Subject(s)
Postoperative Complications , Retinal Perforations/etiology , Retinal Perforations/surgery , Vitrectomy/adverse effects , Vitreous Body/surgery , Aged , Female , Fundus Oculi , Humans , Incidence , Male , Middle Aged , Recurrence , Retrospective Studies , Visual Acuity
20.
Ophthalmology ; 100(11): 1671-6, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8233393

ABSTRACT

BACKGROUND: To surgically treat patients with macular holes, the authors previously reported both anatomic (re-attachment) and visual success (2 lines of improvement) in a series of 52 eyes. They now have operated on an additional 118 eyes using similar techniques, for a total of 170 eyes. METHODS: After ophthalmologic examination and history, the authors operated on suitable patients. The surgical objectives included relief of all tangential traction and retinal tamponade with intraocular gas. All eyes were followed for at least 6 months postoperatively. RESULTS: In the total population of 170 eyes, anatomic success was achieved in 73% and vision improved at least two lines in 55%. Twenty-nine percent (49/170) of patients had a visual acuity of 20/40 or better at last examination. Patients with symptoms of less than 6 months' duration managed better than those with symptoms of longer duration (P = 0.3001). In the former group of 66 eyes, anatomic success was achieved in 80% (n = 53), whereas visual acuity improved at least two lines in 68% (n = 45) and at least four lines in 55% (n = 36). CONCLUSIONS: The authors suggest that macular hole surgery may provide meaningful improvement in visual acuity in most patients, especially in those whose symptoms are of less than 6 months' duration.


Subject(s)
Retinal Perforations/surgery , Vitrectomy , Aged , Female , Follow-Up Studies , Humans , Male , Prognosis , Sulfur Hexafluoride/administration & dosage , Vision, Ocular , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...